SCHEMBL27463121

SCHEMBL27463121

O=C(O)C1Cc2ccccc2N1F

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1445011 0.80 ACE (0.51) ACE
SCHEMBL5847068 0.79 ACE (0.54) ACE
SCHEMBL5847071 0.79 ACE (0.54) ACE
SCHEMBL27439563 0.79 ACE (0.50) ACE
SCHEMBL17461305 0.79 ACE (0.50) ACE
SCHEMBL10339439 0.79 ACE (0.50) ACE
SCHEMBL4278365 0.79 ACE (0.54) ACE
SCHEMBL29443075 0.79 ACE (0.61) ACE
SCHEMBL8633111 0.79 ACE (0.61) ACE
SCHEMBL27924667 0.79 ACE (0.50) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104628621-A Method for preparing fluoro-substituted indol derivative Hunan huateng pharmaceutical co ltd 2015-05-20 — — CN claimed
CN-105254557-A ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RAQUALIA PHARMA INC 2016-01-20 — — CN disclosed
CN-105143200-A Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases ARRAY BIOPHARMA INC 2015-12-09 — — CN disclosed
CN-105130957-A ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RAQUALIA PHARMA INC 2015-12-09 — — CN disclosed
CN-102741222-B Haloalkyl-substituted amides as insecticides and acaricides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-02 — — CN disclosed
CN-102884059-B N-acyl cyclic amine derivatives or pharmaceutically acceptable salts thereof DAINIPPON SUMITOMO PHARMA CO.,LTD. (JP) 2015-08-26 — — CN disclosed
CN-104628621-A Method for preparing fluoro-substituted indol derivative Hunan huateng pharmaceutical co ltd 2015-05-20 — — CN disclosed
CN-103201276-B Indole derivatives RICHTER GEDEON NYRT 2015-02-25 — — CN disclosed
CN-103992326-A Indol-hexahydropyrazine-quinazolinone anti-tumour compounds and preparation method thereof UNIV PLA 2ND MILITARY MEDICAL 2014-08-20 — — CN disclosed
CN-103201276-A Indole derivatives RICHTER GEDEON NYRT 2013-07-10 — — CN disclosed
CN-102884059-A N-acyl cyclic amine derivatives or pharmaceutically acceptable salts thereof DAINIPPON SUMITOMO PHARMA CO 2013-01-16 — — CN disclosed
CN-101501053-B 1- (-D-glucopyranosyl) -3- (4-cyclopropylphenylmethyl) -4-haloindole derivatives and their use as SGLT inhibitors MITSUBISHI TANABE PHARMA CORP 2012-10-03 — — CN disclosed
CN-101501053-A 1- (-D-glucopyranosyl) -3- (4-cyclopropylphenylmethyl) -4-haloindole derivatives and their use as SGLT inhibitors MITSUBISHI TANABE PHARMA CORP (JP) 2009-08-05 — — CN disclosed
CN-101151245-A Indan-amide derivatives with glycogen phosphorylase inhibitory activity ASTRAZENECA AB (SE) 2008-03-26 — — CN disclosed
CN-101128454-A Pyridine carboxamide derivatives for use as anticancer agents ASTRAZENECA AB (SE) 2008-02-20 — — CN disclosed
CN-1142492-A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents PFIZER (US) 1997-02-12 — — CN disclosed
Send feedback